Topline
After examining safety reports from millions of people receiving the Covid-19 vaccine, the UK Medicines and Healthcare products Regulatory Agency (MHRA) on Friday confirmed that they are reaching high levels, which describing the sights from Pfizer-BioNTech and Oxford-AstraZeneca as extremely safe, with only mild side effects.
The UK medicines regulator said the Pfizer and AstraZeneca vaccines were safe and met their high standards. … [+]
POOL / AFP through Getty Images
Key facts
Out of nearly 7 million sightings administered between Dec. 9 and Jan. 24, about 22,820 reported experiencing side effects, about three out of every 1,000 people who were shot.
Most of the side effects reported are mild and lasting, reflecting a normal immune response to vaccines, “the MHRA said, listing sore arm, fatigue and mild” flu-like “symptoms. as examples of common responses.
Adverse allergic reactions (114) were rare and not of concern, and the regulator stated that there were no reasons to believe that any reports of deaths (143) or facial paralysis (75) were linked to the vaccine.
“The data we have collected gives us further confidence that the Covid-19 vaccines are safe and continue to meet the stringent regulatory standards required for all vaccines,” said MHRA chief Dr. Adding June Raine, adding that vaccines are the “most effective” way to protect people against Covid-19.
Important quota
Professor Sir Munir Pirmohamed, chairman of an independent vaccine that assesses vaccine safety for the UK, said the vaccines were “extremely safe.” He said: “The benefits far outweigh the risks . I say that to my family too. “
Key background
The UK was one of the first countries to roll out the vaccine and is one of the most successful. On Wednesday, the British government announced that more than 10 million people, or one in five adults in the UK, had received the first dose of coronavirus vaccine and are on track to deliver their first sighting to the UK. everyone by the end of June. Older and vulnerable people are expected to be vaccinated first and receive images taken by Pfizer-BioNTech, AstraZeneca or Moderna. Britain’s controversial strategy to delay the second dose of the vaccine to provide some form of immunity was recently discovered when a study found that the Oxford-AstraZeneca vaccine could lead to a significant reduction in Covid-19 distribution. with just one dose. The country launched a test this week to see if vaccines from different manufacturers can be used interchangeably.
A large number
10 million. That is how many doses the UK has administered, reaching almost 20% of adults, more than anywhere else in the world except Israel and the UAE.
What we do not know
Naturally, it has its limitations. The data collected by the MHRA only cover the Pfizer-BioNTech and Oxford-AstraZeneca vaccines. The set is heavily stretched towards the Pfizer-BioNTech view. The MHRA also acknowledged that many people who experienced reactions did not appear to be capable.
Further reading
More than a third in UK studies report side effects from Pfizer Coronavirus (Forbes) vaccine
UK launches Covid-19 test to test combination vaccine and maids (Forbes) vaccine program
AstraZeneca vaccine helps slow delivery of covid-19, the first 76% effective dose for at least three months, studies (Forbes) found
Full coverage and live updates on the Coronavirus